The Consortium of Canadian Centres for Clinical Cognitive Research (C5R)

is a not-for-profit research network that facilitates collaboration and partnerships between pharmaceutical companies and Canadian dementia researchers. C5R research sites conduct clinical trials in the desire to research and develop treatments for patients with mild cognitive impairment, Alzheimer’s disease as well as other forms of dementia.